IntelliPharmaCeutics to Ring the NASDAQ Stock Market Opening Bell  
10/26/2012 8:28:35 AM

ADVISORY, Oct. 26, 2012 (GLOBE NEWSWIRE) -- What: Intellipharmaceutics International Inc. [IPCI], a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, will visit the NASDAQ MarketSite in Times Square.